Skip to main content
    What's New in Calcium Pyrophosphate Disease? with Dr. Michael Pillinger

    NYU's Dr. Pillinger talks about Dr. Ann Rosenthal's state of the art talk on calcium pyrophosphate disease at ACR 2020.

    Who has more comorbidities? Dr. Janet Pope

    Dr. Janet Pope reviews abstract #1466 presented at the 2020 ACR annual meeting. Who has more comorbidities: OA, Gout, RA or PsA? 

    Pregnancy Outcomes in AxSpa: Dr. Robert Chao

     

    Dr. Robert Chao reviews abstracts #1498, #1323 and #1324 presented at the 2020 ACR annual meeting. 

    Mavrilimumab in Giant Cell Arteritis: Dr. Richard Conway

    Dr. Conway discusses late-breaking abstract #L06 presented Monday at the ACR 2020 annual meeting.

    Febuxostat bad for the heart? Not so FAST: Dr. Jeffrey Curtis

    Dr. Jeff Curtis from UAB examines the use of Febuxostat (abstract L08) presented at the 2020 ACR annual meeting.

    Antimalarials and Retinopathy: Dr. Janet Pope

    Dr. Janet Pope reviews abstract #1825 at the 2020 ACR annual meeting.

    Hepatitis B, RA and Drug Risk with Drs. Stanley Cohen and Jack Cush

    Dr. Cush interviews past ACR president and long-time friend Dr. Stan Cohen on treatment for liver disease in RA patients and new guidelines being released this morning at ACR 2020.

    GCA Treatment Data: Dr. David Liew Abstract

     

    Dr. David Liew reviews abstracts #0516 and #0513 presented at the 2020 ACR annual meeting.

    Delays in Diagnosis - Axial Spondyloarthritis: Dr Antoni Chan

    Dr. Antoni Chan reviews abstracts #1303 and #1306 presented at the ACR 2020 annual meeting. 

    ABCs of RA: Panel Discussion with Dr. Jonathan Kay

    They're back: from Dublin, Melbourne, Boston, Baltimore and Quezon City, Philippines to discuss top abstracts in the area of RA at the end of day three (Sunday) at ACR 2020, led by Dr. Jonathan Kay. Panelists: Dr. Sheila Reyes, Dr. David Liew, Dr. Eric Dein and Dr. Richard Conway.

    Axial Spondyloarthritis Agents: Dr Antoni Chan

    Dr. Chan reviews several abstracts #1366, #1367 and #1364  at the 2020 ACR annual meeting.

     

    Comorbidities in Gout with Dr. Nicola Dalbeth

    Dr. Dalbeth examines abstracts #1466 and #0660 relating to the comorbidities in Gout at ACR 2020.

    Gut Microbiome and RA: Dr. Robert Chao interviews Dr. Monica Guma

    Dr. Monica Guma reviews her Monday abstract presentation on gut microbiome and improvement in RA (abstract #1994), being presented at the 2020 ACR annual meeting.

    CV Risk in Rheumatoid Arthritis and Osteoarthritis: Dr. Eric Dein

    Dr. Eric Dein reviews abstract #1189 (from the PRECISION trial) presented at the 2020 ACR annual meeting.

    Best Practices for APL Testing: Dr. Michelle Petri

    Dr. Jack Cush interviews Dr. Petri about the comparative value of lupus anticoagulant vs. other antiphospholipid antibody tests and their role in CVA or MI - looking at abstracts #1261#1262 and #1266 presented at the 2020 ACR Annual Meeting.